Einträge von Weyerbrock, Astrid auf dem Publikationsserver

Hau, Peter, Dirven, Linda, Luerding, Ralf, Beier, Dagmar, Bumes, Elisabeth, Reinert, Christiane, Seidel, Clemens, Bonsanto, Matteo Mario, Bremer, Michael, Rieken, Stefan, Combs, Stephanie E., Herrlinger, Ulrich, Seliger, Corinna, Kuntze, Holger, Mayer‑Steinacker, Regine, Dieing, Annette, Bartels, Claudius, Schnell, Oliver, Weyerbrock, Astrid, Seidel, Sabine, Grauer, Oliver, Nadji‑Ohl, Minou, Paulsen, Frank , Weller, Michael und Wick, Wolfgang (2020) Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. Journal of Neuro-Oncology 148, S. 117-130.

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. Journal of Neuro-Oncology 144 (3), S. 501-509. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter , Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589. Volltext nicht vorhanden.

Beier, Dagmar, Proescholdt, Martin, Reinert, Christiane, Pietsch, Torsten, Jones, David T. W. , Pfister, Stefan M. , Hattingen, Elke , Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter (2017) Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro-Oncology 20 (3), S. 400-410. Volltext nicht vorhanden.

Schäfer, Niklas, Proescholdt, Martin, Steinbach, Joachim P, Weyerbrock, Astrid, Hau, Peter , Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W, Uhl, Martin, Grau, Stefan, Hänel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos, Nießen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin und Herrlinger, Ulrich (2017) Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology 20 (7), S. 975-985. Volltext nicht vorhanden.

Herrlinger, Ulrich, Schäfer, Niklas, Steinbach, Joachim P. , Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W. , Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Hänel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Rüdiger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tüttenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter und Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. Journal of Clinical Oncology 34 (14), S. 1611-1619. Volltext nicht vorhanden.

Stupp, Roger, Hegi, Monika E , Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafał, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt , Reardon, David A, van den Bent, Martin J , Hicking, Christine, Markivskyy, Andriy, Picard, Martin und Weller, Michael (2014) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology 15 (10), S. 1100-1108. Volltext nicht vorhanden.

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Stockhammer, Florian, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter und Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. Journal of Clinical Oncology 31 (18_sup), LBA2000-LBA2000. Volltext nicht vorhanden.